Elsevier

The Lancet

Volume 366, Issue 9480, 9–15 July 2005, Pages 172-174
The Lancet

Viewpoint
The Good Clinical Practice guideline: a bronze standard for clinical research

https://doi.org/10.1016/S0140-6736(05)66875-4Get rights and content

Section snippets

Background

Documentation of compliance with GCP is required for all submissions approved by regulatory agencies in the European Union, the USA, Japan, and Canada. A series of numbered ICH “efficacy” guidelines have been developed on various topics (E1 through E12A). This voluminous material (now totalling 367 pages) can be confusing (eg, when downloaded from different web sites, some identical documents have different titles and dates). The document on which we will mainly focus is “Good Clinical

Deficiencies of GCP

The term “Good Clinical Practice” is a misnomer (table). This unofficial jargon refers to US Food and Drug Administration regulations and guidelines organised within the US Code of Federal Regulations.2 Unfortunately, other organisations, such as the UK Medical Research Council, have adopted the GCP misnomer. “Good Clinical Practice” here does not relate to clinical practice, but, rather, to the conduct of clinical research.

Four general approaches to guideline development exist: informal

Solutions

One option would be to drop the GCP requirement for research that is not destined for a regulatory agency. Much of the documentation required by ICH-E6 has no relevance to research validity or reliability. Given its burdensome requirements, insistence on GCP for non-regulatory research seems poorly advised.

A second solution would be to revise GCP. Although ICH-E6 contains much useful material, its development process was neither inclusive nor evidence-based.3 Moreover, ICH-E6 is obsolete and

First page preview

First page preview
Click to open first page preview

References (22)

  • AD Sniderman

    Clinical trials, consensus conferences, and clinical practice

    Lancet

    (1999)
  • RP Schwarz

    Maintaining integrity and credibility in industry-sponsored clinical research

    Control Clin Trials

    (1991)
  • R Peto et al.

    The trials of Dr Bernard Fisher: a European perspective on an American episode

    Control Clin Trials

    (1997)
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6

  • JR Dixon

    The International Conference on Harmonization Good Clinical Practice guideline

    Qual Assur

    (1998)
  • SH Woolf

    Practice guidelines, a new reality in medicine. II. Methods of developing guidelines

    Arch Intern Med

    (1992)
  • S Sauerland et al.

    Consensus conferences must include a systematic search and categorization of the evidence

    Surg Endosc

    (2000)
  • PG Shekelle et al.

    Clinical guidelines: developing guidelines

    BMJ

    (1999)
  • J Abraham et al.

    Trading risks for markets: the international harmonisation of pharmaceuticals regulation

    Health Risk Soc

    (2001)
  • KF Schulz et al.

    Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

    JAMA

    (1995)
  • International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. The future of ICH—Revised

  • Cited by (135)

    View all citing articles on Scopus
    View full text